{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:48:44Z","timestamp":1781207324256,"version":"3.54.1"},"reference-count":52,"publisher":"XMLink","issue":"2","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["ejgo.org"],"crossmark-restriction":false},"short-container-title":["J Gynecol Oncol"],"DOI":"10.3802\/jgo.2022.33.e43","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T06:36:56Z","timestamp":1646030216000},"update-policy":"https:\/\/doi.org\/10.3802\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Major clinical research advances in gynecologic cancer in 2021"],"prefix":"10.3802","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2475-7123","authenticated-orcid":false,"given":"Jeong-Yeol","family":"Park","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7948-1350","authenticated-orcid":false,"given":"Jung-Yun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5902-9877","authenticated-orcid":false,"given":"Yoo-Young","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8043-2257","authenticated-orcid":false,"given":"Seung-Hyuk","family":"Shim","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4312-966X","authenticated-orcid":false,"given":"Dong Hoon","family":"Suh","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1835-9436","authenticated-orcid":false,"given":"Jae-Weon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18617","published-online":{"date-parts":[[2022]]},"reference":[{"key":"10.3802\/jgo.2022.33.e43_ref1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/jamaoncol.2020.7168","volume":"7","author":"Huang","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref2","doi-asserted-by":"crossref","first-page":"S1314","DOI":"10.1016\/j.annonc.2021.08.2116","volume":"32","author":"Luke","year":"2021","journal-title":"Ann Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref3","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","volume":"385","author":"Colombo","year":"2021","journal-title":"N Engl J Med"},{"key":"10.3802\/jgo.2022.33.e43_ref4","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.annonc.2021.04.009","volume":"32","author":"Tewari","year":"2021","journal-title":"Ann Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(21)00056-5","volume":"22","author":"Coleman","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref6","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/ijgc-2021-002921","volume":"31","author":"Schmeler","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.3802\/jgo.2022.33.e43_ref7","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref8","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ijrobp.2015.09.001","volume":"93","author":"Trifiletti","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.3802\/jgo.2022.33.e43_ref9","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1093\/annonc\/mdr628","volume":"23","author":"Sehouli","year":"2012","journal-title":"Ann Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref10","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1200\/JCO.2009.25.9663","volume":"29","author":"Due\u00f1as-Gonz\u00e1lez","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref11","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1902626","volume":"381","author":"Coleman","year":"2019","journal-title":"N Engl J Med"},{"key":"10.3802\/jgo.2022.33.e43_ref12","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1056\/NEJMoa2103294","volume":"385","author":"Harter","year":"2021","journal-title":"N Engl J Med"},{"key":"10.3802\/jgo.2022.33.e43_ref13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1470-2045(21)00006-1","volume":"22","author":"Shi","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref14","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1200\/JCO.21.00306","volume":"39","author":"Moore","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref15","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S1470-2045(21)00342-9","volume":"22","author":"Monk","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref16","doi-asserted-by":"crossref","first-page":"TPS5598","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS5598","volume":"37","author":"Harter","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref17","doi-asserted-by":"crossref","first-page":"TPS5600","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS5600","volume":"37","author":"Hardy-Bessard","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref18","doi-asserted-by":"crossref","first-page":"TPS5603","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS5603","volume":"37","author":"Vergote","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref19","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1136\/ijgc-2021-002933","volume":"31","author":"Monk","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.3802\/jgo.2022.33.e43_ref20","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1200\/JCO.2021.39.15_suppl.5505","volume":"39","author":"Westin","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2021.08.024","volume":"163","author":"Shah","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref22","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1200\/JCO.2021.39.15_suppl.5516","volume":"39","author":"Wethington","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref23","doi-asserted-by":"crossref","first-page":"S1287","DOI":"10.1016\/j.annonc.2021.08.2087","volume":"32","author":"Cort\u00e9s","year":"2021","journal-title":"Ann Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/jnci\/djx214","volume":"110","author":"Lortet-Tieulent","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.3802\/jgo.2022.33.e43_ref25","unstructured":"National Cancer Institute. Cancer stat facts: uterine cancer [Internet]. Bethesda, MD. National Cancer Institute. 2021. cited 2022 Jan 30. Available from:  https:\/\/seer.cancer.gov\/statfacts\/html\/corp.html"},{"key":"10.3802\/jgo.2022.33.e43_ref26","unstructured":"Cancer Research UK. Uterine cancer mortality statistics [Internet]. Oxford. Cancer Research UK. 2021. cited 2022 Jan 30. Available from:  https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/uterine-cancer\/mortality#heading-Three"},{"key":"10.3802\/jgo.2022.33.e43_ref27","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/bjc.2016.304","volume":"115","author":"Smittenaar","year":"2016","journal-title":"Br J Cancer"},{"key":"10.3802\/jgo.2022.33.e43_ref28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/AOG.0b013e31827499a9","volume":"121","author":"Novetsky","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.3802\/jgo.2022.33.e43_ref29","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1200\/JCO.2021.39.15_suppl.5506","volume":"39","author":"Zola","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/modpathol.2009.153","volume":"23","author":"Garg","year":"2010","journal-title":"Mod Pathol"},{"key":"10.3802\/jgo.2022.33.e43_ref31","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1634\/theoncologist.2015-0149","volume":"20","author":"Diver","year":"2015","journal-title":"Oncologist"},{"key":"10.3802\/jgo.2022.33.e43_ref32","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1158\/1078-0432.CCR-20-0953","volume":"26","author":"Fader","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.3802\/jgo.2022.33.e43_ref33","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/ijgc-2021-002753","volume":"31","author":"Ferriss","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.3802\/jgo.2022.33.e43_ref34","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","volume":"38","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.3802\/jgo.2022.33.e43_ref36","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1001\/jamaoncol.2020.1046","volume":"6","author":"Petrelli","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref37","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1056\/NEJMoa2108330","volume":"386","author":"Makker","year":"2022","journal-title":"N Engl J Med"},{"key":"10.3802\/jgo.2022.33.e43_ref38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/1471-0528.14000","volume":"124","author":"Beaver","year":"2017","journal-title":"BJOG"},{"key":"10.3802\/jgo.2022.33.e43_ref39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13063-018-2611-x","volume":"19","author":"Ezendam","year":"2018","journal-title":"Trials"},{"key":"10.3802\/jgo.2022.33.e43_ref40","unstructured":"U.S. National Library of Medicine. ENdometrial Cancer SURvivors' Follow-up carE (ENSURE): less is more? (ENSURE) [Internet]. Bethesda, MD. National Institutes of Health. 2019. cited 2022 Jan 30. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02413606"},{"key":"10.3802\/jgo.2022.33.e43_ref41","unstructured":"U.S. National Library of Medicine. Follow-up of endometrial cancer patients (OPAL) [Internet]. Bethesda, MD. National Institutes of Health. 2017. cited 2022 Jan 30. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01853865"},{"key":"10.3802\/jgo.2022.33.e43_ref42","unstructured":"U.S. National Library of Medicine. Study of TSR-042, an anti-programmed cell death-1 receptor (PD-1) monoclonal antibody, in participants with advanced solid tumors (GARNET) [Internet]. Bethesda, MD. National Institutes of Health. 2022. cited 2022 Jan 30. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02715284"},{"key":"10.3802\/jgo.2022.33.e43_ref43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jitc-2021-003777","volume":"10","author":"Oaknin","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.3802\/jgo.2022.33.e43_ref44","unstructured":"U.S. National Library of Medicine. A study to evaluate dostarlimab plus carboplatin-paclitaxel versus placebo plus carboplatin-paclitaxel in participants with recurrent or primary advanced endometrial cancer (RUBY) [Internet]. Bethesda, MD. National Institutes of Health. 2021. cited 2022 Jan 30. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03981796"},{"key":"10.3802\/jgo.2022.33.e43_ref45","unstructured":"U.S. National Library of Medicine. Testing the addition of the immunotherapy drug pembrolizumab to the usual chemotherapy treatment (paclitaxel and carboplatin) in stage III-IV or recurrent endometrial cancer [Internet]. Bethesda, MD. National Institutes of Health. 2022. cited 2022 Jan 30. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03914612"},{"key":"10.3802\/jgo.2022.33.e43_ref46","unstructured":"U.S. National Library of Medicine. Atezolizumab trial in endometrial cancer - AtTEnd (AtTEnd) [Internet]. Bethesda, MD. National Institutes of Health. 2022. cited 2022 Jan 30. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03603184"},{"key":"10.3802\/jgo.2022.33.e43_ref47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1200\/JCO.2019.37.15_suppl.5539","volume":"37","author":"Colombo","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref48","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1200\/JCO.19.02627","volume":"38","author":"Makker","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1200\/JCO.2020.38.15_suppl.TPS6106","volume":"38","author":"Marth","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2022.33.e43_ref50","unstructured":"U.S. National Library of Medicine. Pembrolizumab (MK-3475) plus lenvatinib (E7080\/MK-7902) versus chemotherapy for endometrial carcinoma (ENGOT-en9 \/ MK-7902-001) (LEAP-001) [Internet]. Bethesda, MD. National Institutes of Health. 2021. cited 2022 Jan 30. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03884101"},{"key":"10.3802\/jgo.2022.33.e43_ref51","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet"},{"key":"10.3802\/jgo.2022.33.e43_ref52","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/jamaoncol.2021.1590","volume":"7","author":"Steenbeek","year":"2021","journal-title":"JAMA Oncol"}],"container-title":["Journal of Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ejgo.org\/pdf\/10.3802\/jgo.2022.33.e43","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ejgo.org\/DOIx.php?id=10.3802\/jgo.2022.33.e43","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ejgo.org\/DOIx.php?id=10.3802\/jgo.2022.33.e43","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T08:19:48Z","timestamp":1646036388000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejgo.org\/DOIx.php?id=10.3802\/jgo.2022.33.e43"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":52,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.3802\/jgo.2022.33.e43","relation":{},"ISSN":["2005-0380","2005-0399"],"issn-type":[{"value":"2005-0380","type":"print"},{"value":"2005-0399","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"2022-02-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-20","name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-25","name":"published_online","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"Copyright \u00a9 2022. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}],"article-number":"e43"}}